• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis.

作者信息

Mrowietz Ulrich, Riedl Elisabeth, Winkler Stefan, Xu Wen, Patel Himanshu, Agada Noah, Lebwohl Mark G

机构信息

Psoriasis Center, University Medical Center Schleswig-Holstein, Campus Kiel, Germany.

Department of Dermatology, Medical University of Vienna, Vienna, Austria; Eli Lilly and Company, Indianapolis, Indiana, USA.

出版信息

J Am Acad Dermatol. 2020 Nov;83(5):1436-1439. doi: 10.1016/j.jaad.2020.06.012. Epub 2020 Jun 8.

DOI:10.1016/j.jaad.2020.06.012
PMID:32526319
Abstract
摘要

相似文献

1
No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis.接受司库奇尤单抗治疗的潜伏性结核感染患者未出现结核病再激活：来自16项银屑病或银屑病关节炎患者临床研究的报告
J Am Acad Dermatol. 2020 Nov;83(5):1436-1439. doi: 10.1016/j.jaad.2020.06.012. Epub 2020 Jun 8.
2
Safety of secukinumab in psoriasis patients with latent tuberculosis infection.苏金单抗在潜伏性结核感染银屑病患者中的安全性。
Eur J Dermatol. 2020 Dec 1;30(6):740-741. doi: 10.1684/ejd.2020.3909.
3
Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.司库奇尤单抗用于治疗中度至重度斑块状银屑病和银屑病关节炎的成人患者。
Expert Rev Clin Pharmacol. 2016 Nov;9(11):1423-1433. doi: 10.1080/17512433.2016.1242409. Epub 2016 Oct 11.
4
Association of psoriasis/psoriatic arthritis with inflammatory bowel disease influences management strategy.银屑病/银屑病关节炎与炎症性肠病的关联会影响治疗策略。
J Eur Acad Dermatol Venereol. 2019 Nov;33(11):e431-e432. doi: 10.1111/jdv.15752. Epub 2019 Jul 2.
5
Latent tuberculosis reactivation in a patient with erythrodermic psoriasis under treatment with ustekinumab and a low dose steroid, despite isoniazid chemoprophylaxis.尽管接受了异烟肼化学预防，但一名正在接受乌司奴单抗和低剂量类固醇治疗的红皮病型银屑病患者仍出现了潜伏性结核再激活。
Eur J Dermatol. 2014 Jul-Aug;24(4):508-9. doi: 10.1684/ejd.2014.2386.
6
Ixekizumab in hidradenitis suppurativa in a psoriatic patient.司库奇尤单抗治疗一名银屑病患者的化脓性汗腺炎
G Ital Dermatol Venereol. 2020 Dec;155(6):788-789. doi: 10.23736/S0392-0488.18.06135-7. Epub 2019 Jan 9.
7
Ixekizumab for the treatment of psoriasis: an update on new data since first approval.依奇珠单抗治疗银屑病：首次批准以来新数据的更新。
Expert Rev Clin Immunol. 2019 Feb;15(2):111-121. doi: 10.1080/1744666X.2019.1559730. Epub 2018 Dec 27.
8
Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).司库奇尤单抗治疗日本中重度斑块状银屑病、红皮病型银屑病和泛发性脓疱型银屑病患者的疗效和安全性：一项为期52周的开放标签3期研究（UNCOVER-J）的结果
J Dermatol. 2017 Apr;44(4):355-362. doi: 10.1111/1346-8138.13622. Epub 2016 Oct 11.
9
Ixekizumab in the treatment of psoriatic arthritis.依奇珠单抗治疗银屑病关节炎。
Immunotherapy. 2021 Jan;13(1):19-33. doi: 10.2217/imt-2020-0225. Epub 2020 Nov 9.
10
Ixekizumab-associated disseminated tinea corporis in a patient with psoriatic arthritis and plaque psoriasis.患有银屑病关节炎和斑块状银屑病的患者出现与司库奇尤单抗相关的播散性体癣。
Rheumatology (Oxford). 2023 Jun 1;62(6):e209-e210. doi: 10.1093/rheumatology/keac635.

引用本文的文献

1
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study.使用 IL-17 和 IL-23 抑制剂治疗潜伏性结核病的银屑病患者：一项回顾性、多国、多中心研究。
Am J Clin Dermatol. 2024 Mar;25(2):333-342. doi: 10.1007/s40257-024-00845-4. Epub 2024 Jan 24.
2
Incidence of New-Onset Inflammatory Bowel Disease, Oral and Gastrointestinal Candidiasis, Herpes Zoster, Pulmonary Tuberculosis, and Major Cardiovascular Events in Patients with Moderate-to-Severe Psoriasis Exposed to Biologics.暴露于生物制剂的中重度银屑病患者新发炎症性肠病、口腔和胃肠道念珠菌病、带状疱疹、肺结核及主要心血管事件的发生率。
J Clin Med. 2023 Dec 13;12(24):7653. doi: 10.3390/jcm12247653.
3
The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies.
接受司库奇尤单抗和依奇珠单抗（抗白细胞介素-17A 单克隆抗体）治疗的银屑病患者中，QuantiFERON-TB Gold In-Tube 检测的血清转化率。
PLoS One. 2019 Dec 27;14(12):e0225112. doi: 10.1371/journal.pone.0225112. eCollection 2019.